E.g., 04/23/2021
E.g., 04/23/2021
Title Category Credit Event Date Pricesort ascending
Audio Playlist $0.00
Update Series Index Volumes 1-39 $0.00 AUA Update Series Index Volumes 1-39
Update Series (2016) Lesson 11: Surgical Treatment of SUI in 2016— What is the Role of the Mid-Urethral Sling? $0.00 For the most timely topics and latest surgical techniques in urology, you won't want to miss the 2016 AUA Update Series—AUA's most popular self-study CME product.Concise, practical lessons on timely topicsState-of-the-art surgical techniquesAuthors are among the best in their specialtiesEarn up to 40 AMA PRA Category 1 Credits™
Update Series (2020): Test Your Knowledge Lessons 1-5 $0.00 For our annual subscribers, we are excited to continue to offer a new feature to the Update Series! If you like to answer questions to help you study and learn, we are now offering Test Your Knowledge activities with each release of the Update Series.This new feature:
Update Series (2016) Lesson 27: Intravesical Chemotherapy for Non-Muscle Invasive Bladder Cancer $0.00 For the most timely topics and latest surgical techniques in urology, you won't want to miss the 2016 AUA Update Series—AUA's most popular self-study CME product.Concise, practical lessons on timely topicsState-of-the-art surgical techniquesAuthors are among the best in their specialtiesEarn up to 40 AMA PRA Category 1 Credits™
2020 Guideline: Advanced Prostate Cancer Webcast (2020)
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 Non-Physician Participation
$0.00 This course will review the important and newly updated 2020 AUA Guidelines on Metastatic Hormone Sensitive (HSPC) and Castration-Resistant Prostate Cancer (CRPC). This includes a thorough discussion of new trials and approval of agents directed at the androgen axis for treatment of M1 HSPC and non-metastatic MO CRPC. Faculty will highlight the management of patients with advanced prostate cancer, including mHSPC, nmCRPC, and CRPC, and how therapeutic options have been incorporated into evidence-based guidelines.
Advanced Practice Provider Core Curriculum: Testicular Neoplasm (2020)
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 Non-Physician Participation
$0.00 Member only benefit! Results of a recent survey sent to US based practicing urologists show that there has been an increase in the number of advanced practice providers (APPs) actively providing front-line urologic care. Based on these findings, it was determined that the AUA develop a modular curriculum to be used in advancing the standard of urologic education for APP’s. This educational curriculum, developed in partnership with the Cleveland Clinic, is comprised of online videos targeted towards the most common reasons patients seek non-operative urologic care.
Update Series (2019) Lesson 7: Establishment of a Quality Assurance Framework for Introduction of Prostate Magnetic Resonance Imaging and Fusion...
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Now in its 38th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed in consultation with and edited by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology.
Update Series (2015) Lesson 1: Erectile Dysfunction in the Younger Man $0.00 For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015!
AUA Guidelines: Evaluation and Management of Localized Renal Masses: A Case-Based Approach Webcast (2020)
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 Non-Physician Participation
$0.00 This course will be interactive and case-based with imaging and videos that will lead into discussion of the most important AUA Guidelines recommendations. A primary focus will be surgical management and efforts to reduce the risk of complications, manage intraoperative complications, or optimize oncologic and functional outcomes. We will each take 3-5 minutes to highlight one recent major development in the field of kidney cancer.ACKNOWLEDGEMENTSSupport provided by independent educational grants from:
Update Series (2015) Lesson 18: Genitourinary Trauma $0.00 For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015!
Update Series (2021) Lesson 1: Genomic Biomarkers for Clinically Localized Prostate Cancer
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Audio Lessons - Listen on-the-go!This enhanced feature is FREE to all Update Series subscribers. Stream audio recordings of all 40 lessons conveniently from your mobile device! Access the Audio Lesson in the AUAUniversity app and within the AUAU  lesson Content page.
Update Series (2015) Lesson 34: Substitution Urethroplasty: Techniques Using Grafts and Flaps for Male Anterior Urethral Reconstruction $0.00 For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015!
Update Series (2021): Test Your Knowledge Lessons 1-5 $0.00 For our annual subscribers, we are excited to continue to offer a new feature to the Update Series! If you like to answer questions to help you study and learn, we are now offering Test Your Knowledge activities with each release of the Update Series.This new feature:
Metastatic Hormone Sensitive Prostate Cancer: Expert Guidance for Urologists Webcast (2021)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 In just the last decade, the FDA has approved several new therapies for the treatment of prostate cancer. It is critical for urologists to understand the sequencing of agents for the treatment of mHSPC because of the overlapping toxicities and the increasing role for treating mHSPC patients. For each new agent, urologists should be able to identify the active agents and their mechanism of action, analyze the breakthrough treatments in the management of advanced and mHSPC, and describe the indications and combinations for treatment with approved agents in the management of mHSPC.

Pages